Crossmark

LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer

Crossref DOI link: https://doi.org/10.1038/s41388-018-0193-4

Published Online: 2018-03-16

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, S.

Zou, Z.

Luo, X.

Mi, Y.

Chang, H.

Xing, D.
License Information

Text and Data Mining valid from 2018-03-16
More Information

Article History

Received: 22 June 2017

Revised: 30 January 2018

Accepted: 2 February 2018

First Online: 16 March 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.